🇺🇸 FDA
Patent

US 11833148

Methods for treating or limiting development of cardiovascular disease-related neurological disorders

granted A61KA61K31/4439A61K31/496

Quick answer

US patent 11833148 (Methods for treating or limiting development of cardiovascular disease-related neurological disorders) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/4439, A61K31/496, A61P, A61P25/28